CAPLIN POINT LABORATORIES LTD.
Quaterly Results
Particulars | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | Audited | UnAudited | UnAudited |
Net Sales | 4532.2 | 4355 | 4100.6 | 3953.2 |
Total Expenditure | 3079.9 | 2932.2 | 2726.6 | 2687.9 |
PBIDT (Excl OI) | 1452.3 | 1422.8 | 1374 | 1265.3 |
Other Income | 172.9 | 171.8 | 204.3 | 120.4 |
Operating Profit | 1625.2 | 1594.6 | 1578.3 | 1385.7 |
Interest | 1.5 | 1.7 | 1.8 | 2.8 |
Exceptional Items | NA | NA | NA | NA |
PBDT | 1623.7 | 1592.9 | 1576.5 | 1382.9 |
Depreciation | 164 | 139 | 117.6 | 113.8 |
Profit Before Tax | 1459.7 | 1453.9 | 1458.9 | 1269.1 |
Tax | 248 | 255.9 | 298.6 | 227.6 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | 1211.7 | 1198 | 1160.3 | 1041.5 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | 1211.7 | 1198 | 1160.3 | 1041.5 |
Minority Interest | 3.6 | -26.2 | -12.7 | -8 |
Shares of Associates | 0.6 | 0.2 | 1.1 | 0.8 |
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | 1215.9 | 1172 | 1148.7 | 1034.3 |
Equity Capital | 151.9 | 151.9 | 151.9 | 151.9 |
Face Value (IN RS) | 2 | 2 | 2 | 2 |
Reserves | NA | NA | NA | NA |
Calculated EPS | 16.00 | 15.43 | 15.12 | 13.61 |
Calculated EPS (Annualised) | 64.03 | 61.72 | 60.49 | 54.47 |
No of Public Share Holdings | 22308764 | 22308764 | 22306764 | 22300764 |
% of Public Share Holdings | 29.38 | 29.38 | 29.37 | 29.37 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | 32.04 | 32.67 | 33.50 | 32.00 |
PBIDTM% | 35.85 | 36.61 | 38.48 | 35.05 |
PBDTM% | 35.82 | 36.57 | 38.44 | 34.98 |
PBTM% | 32.20 | 33.38 | 35.57 | 32.10 |
PATM% | 26.73 | 27.50 | 28.29 | 26.34 |
"; | Notes | Notes | Notes | Notes |